Overview
A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain
Status:
Withdrawn
Withdrawn
Trial end date:
2010-12-12
2010-12-12
Target enrollment:
0
0
Participant gender:
All
All
Summary
The investigators hypothesize that cyclooxygenas-II-selective inhibitors (Coxibs) provide a better patients assessed overall satisfaction when used for pain management after elective hallux valgus surgery as compared to traditional Non-steroidal anti-inflammatory drugs (NSAIDs).Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Karolinska InstitutetTreatments:
Diclofenac
Etoricoxib
Criteria
Inclusion Criteria:- American Society of Anesthesiology (ASA) physiological class 1-2 patients
- aged 18-65 years
- scheduled for elective hallux valgus surgery in general anesthesia
Exclusion Criteria:
- NSAID allergy
- liver disease
- renal disease
- uncontrolled cardiovascular disease
- Lithium therapy
- chronic pain
- regular analgesia use